Form 4 for IDXX Idexx Laboratories
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001567619-22-004785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-16 | 2022-02-14 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | +781 | 15.1K | +5% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | POLEWACZYK JAMES F | EVP | F - Tax | $505.53 | +235 | 15.4K | +2% | +$118.8K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | — | -781 | 2,740 | -22% | — |
| DM | 2022-02-16 | 2022-02-14 | IDXX | POLEWACZYK JAMES F | EVP | A - Grant | — | +8,022 | 2,890 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 127 | $0.00 | 15,231.28 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-14 | M | A | 217 | $0.00 | 15,448.28 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-14 | F | A | 235 | $505.53 | 15,374.28 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-14 | M | A | 161 | $0.00 | 15,609.28 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-14 | M | A | 150 | $0.00 | 14,978.28 | D | — | — | (F1) Includes 10 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2021. |
| 6 | Common | Common Stock | 2022-02-14 | M | A | 126 | $0.00 | 15,104.28 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 126 | — | 2,614 | D | — · — to — | 126 Common Stock | (F10) Not applicable. (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. |
| 8 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 127 | — | 2,487 | D | — · — to — | 127 Common Stock | (F10) Not applicable. (F7) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 9 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 217 | — | 2,270 | D | — · — to — | 217 Common Stock | (F10) Not applicable. (F8) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 10 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 161 | — | 2,109 | D | — · — to — | 161 Common Stock | (F10) Not applicable. (F9) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 11 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2022-02-14 | A | A | 7,009 | — | 7,009 | D | $505.53 · — to 2032-02-13 | 7,009 Common Stock | (F10) Not applicable. (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. |
| 12 | Derivative | Incentive Stock Option (right-to-buy) | 2022-02-14 | A | A | 197 | — | 197 | D | $505.53 · — to 2032-02-13 | 197 Common Stock | (F10) Not applicable. (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. |
| 13 | Derivative | Restricted Stock Unit | 2022-02-14 | A | A | 816 | — | 2,890 | D | — · — to — | 816 Common Stock | (F10) Not applicable. (F4) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| 14 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 150 | — | 2,740 | D | — · — to — | 150 Common Stock | (F10) Not applicable. (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2018. |